EVONIK INDUSTRIES AG Evonik
Leading Beyond Chemistry
Company Presentation Q1 2021
Key Messages Q1 2021
Strong start into the year driven by "specialty growth"
Specialty growth
- Higher sales and adj. EBITDA in all three growth divisions - both vs. Q1 2020 and the pre- pandemic levels in Q1 20219
- Specialty Additiveswith further margin expansion on the back of strong demand across the division
- Nutrition & Carewith clear margin improvement driven by shift to system solutions, active cost management and increasing prices
- Smart Materialsrecording strong volume growth supported by ongoing macro-economic recovery
Strong start into the year
- Adj. EBITDAup 15% yoy at €588 m
- Record-highfree cash flowfor a first quarter
(€312 m)
Outlook range narrowed upwards
- Adj. EBITDAexpected between €2.1 and 2.3 bn (previously: between €2.0 and 2.3 bn)
- Driven by upgraded divisional outlook for Specialty Additives and Nutrition & Care
- Targeting growth above 2019pre-pandemic level
2 | May / June 2021 | Evonik Q1 2021 Company Presentation
Table of contents
- Evonik at a glance
- Strategy
- Financials Q1 2021
- Appendix
3 | May / June 2021 | Evonik Q1 2021 Company Presentation
LEADING BEYOND CHEMISTRY
TO IMPROVE LIFE, TODAY AND TOMORROW
4 | May / June 2021 | Evonik Q1 2021 Company Presentation
Leading Beyond Chemistry - Our purpose
Evonik on the way to become a best-in-class specialty chemicals company
Video "We are Evonik"
Leading …
… Beyond …
… Chemistry
- Leading market positions in80%of our business
- Leadingkey financial indicators
- Connecting skillsand perspectives
- Developsolutionstogether with partners
- Sustainabilitykey driver of growth
- Clear focus onspecialty chemicals
- Target100% specialtyportfolio
5 | May / June 2021 | Evonik Q1 2021 Company Presentation
Attachments
- Original document
- Permalink
Disclaimer
Evonik Industries AG published this content on 20 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2021 07:05:01 UTC.
